Amebiasis Overview
Learn About Amebiasis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Unm Medical Group Inc
James Chodosh is an Ophthalmologist in Albuquerque, New Mexico. Dr. Chodosh and is rated as an Experienced provider by MediFind in the treatment of Amebiasis. His top areas of expertise are Stevens-Johnson Syndrome, Erythema Multiforme, Interstitial Keratitis, Corneal Transplant, and Vitrectomy. Dr. Chodosh is currently accepting new patients.
Unm Medical Group Inc
Alexander Davis is an Ophthalmologist in Albuquerque, New Mexico. Dr. Davis and is rated as an Experienced provider by MediFind in the treatment of Amebiasis. His top areas of expertise are Fuchs Dystrophy, Corneal Dystrophy and Perceptive Deafness, Macular Corneal Dystrophy Type 1, Interstitial Keratitis, and Corneal Transplant.
Unm Medical Group Inc
Abu Sheikh is an Internal Medicine provider in Albuquerque, New Mexico. Dr. Sheikh has been practicing medicine for over 9 years and is rated as an Experienced provider by MediFind in the treatment of Amebiasis. His top areas of expertise are COVID-19, Sepsis, Diabetes Insipidus (DI), Thrombectomy, and Endoscopy.
Summary: This will be a non-interventional study with secondary use of data. The study will be a site-based retrospective review of medical chart of patients with AK who initiated and completed a treatment with 0.8 mg/ml polihexanide as part of a compassionate use program. Patientlevel data will be abstracted from medical chart of eligible patients at participating sites and imputed in an electronic case r...
Summary: The Parasitic Ulcer Treatment Trial (PUTT) is a multi-center, parallel-group, randomized clinical trial. The purpose of this study is to determine whether including topical corticosteroids in a regimen for acanthamoeba keratitis (AK) will improve vision. Patients presenting to all enrollment centers with evidence of acanthamoeba keratitis will be eligible for the trial if there is evidence of ocul...